Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood

Journal of Clinical Endocrinology and Metabolism

Volumn 59, Issue 3, 1984, Pages 551-555

  Orentreich, Norman ^a   Brind, Joel L ^a   Rizer, Ronald L ^a   Vogelman, Joseph H ^a  

^a Orentreich Foundation for the Advancement of Science Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

AGE; BIOLOGICAL MODEL; ENDOCRINE SYSTEM; HUMAN; NORMAL HUMAN; SERUM; SEX; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGING; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; PRASTERONE; RADIOIMMUNOASSAY; SEX FACTORS;

EID: 0021181906     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-59-3-551     Document Type: Article

References (20)

1. Baulieu EE 1962 Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endocrinol Metab 22:501
2. Vande Wiele RL, MacDonald PC, Gurpide E, Lieberman S 1963 Studies on the secretion and interconversion of the androgens. Recent Prog Horm Res 19:275
3. DePeretti E, Forest MG 1978 Pattern of plasma dehydroepian-drosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J Clin Endocrinol Metab 47:572
4. Yamaji T, Ibayashi H 1969 Plasma dehydroepiandrosterone sulfate in normal and pathological conditions. J Clin Endocrinol Metab 29:273
5. Vihko R 1966 Gas chromatographic-mass spectrometric studies on solvolyzable steroids in human peripheral plasma. Acta Endocrinol [Suppl 109] (Copenh) 52:7
6. Smith MR, Rudd BT, Shirley A, Rayner PHW, Williams JW, Duignan NM, Bertrand PV 1975 A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulfate in normal and pathological sera. Clin Chim Acta 65:5
7. Wang DY, Bulbrook RD, Thomas BS, Friedman M 1968 Determination of solvolyzed sulfate esters of dehydroepiandrosterone and androsterone in human peripheral plasma by gas-liquid chromatography. J Endocrinol 42:567
8. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK 1980 Sex differences in the twenty-four-hour mean plasma concentrations of dehydroepiandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51:330
9. David R, Landin L, Drucker W 1980 Plasma dehydroepiandrosterone sulfate in hypothalamic-pituitary dysfunction. In: Genazzani AR, Thijssen JHH, Siiteri PK (eds) Adrenal Androgens, Siena, Raven Press, New York, p 309
10. Buster JE, Abraham GE 1972 Radioimmunoassay of plasma dehydroepiandrosterone sulfate. Anal Lett 5:543
11. Abraham GE 1975 Radioimmunoassay of steroids in biological fluids. J Steroid Biochem 6:261
12. Bulbrook RD, Hayward JL, Spicer CC 1971 Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 2:395
13. Brownsey B, Cameron EHD, Griffiths K, Gleave EN, Forest APM, Campbell H 1971 Plasma dehydroepiandrosterone sulfate levels in patients with benign and malignant breast disease. Eur J Cancer 8:131
14. Fisher RA 1936 Statistical Methods for Research Workers, ed 6. Oliver and Boyd, Edinburgh
15. Rowe JW 1977 Clinical research on aging: strategies and directions. N Engl J Med 297:1332
16. Sanberg E, Gurpide E, Lieberman S 1964 Quantitative studies on the metabolism of dehydroepiandrosterone sulfate. Biochemistry 3:1256
17. Zumoff B, Bradlow HL 1980 Sex difference in the metabolism of dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 51:334
18. Rosenfeld RS, Rosenberg BJ, Fukushima DK, Heilman L 1975 24-Hour secretory pattern of dehydroisoandrosterone and dehydro-isoandrosterone sulfate. J Clin Endocrinol Metab 40:850
19. Read GF, Wilson DW, Campbell FC, Holliday HW, Blarney RW, Griffiths K 1983 Salivary cortisol and dehydroepiandrosterone sulfate levels in postmenopausal women with primary breast cancer. Eur J Cancer Clin Oncol 19:477
20. Zumoff B, Levin J, Rosenfeld RS, Markham M, Strain GW, Fukushima DK 1981 Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res 41:3360